SEC Form 6-K filed by Quantum Biopharma Ltd.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of: October 2024
Commission File Number: 001-39152
| QUANTUM BIOPHARMA LTD. |
| (Translation of registrant's name into English) |
55 University Ave., Suite 1003
Toronto, Ontario M5J 2H7, Canada
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
| Quantum BioPharma Ltd. (Registrant) |
| |
|
|
|
|
|
| Date: October 22, 2024 | By: | /s/ Donal Carroll |
|
|
|
| Donal Carroll, Chief Financial Officer |
|
| 2 |
EXHIBIT INDEX
| Exhibit |
| Description |
|
|
|
|
|
|
| 3 |